GST, weak US Dollar and Malaysia costs impacted June quarter: Biocon
Shares of Biocon fell over 3 per cent on 28 July after the pharma company reported a 51.20 per cent decline in its consolidated net profit to Rs 81.3 crore for the quarter ended June 30, on account of weakening of the US Dollar and GST impact.